Analysts expect Aptevo Therapeutics Inc. (Nasdaq: APVO) to fall to a loss for the current quarter. The stock price tumbled $1.25 to close at $3.14.
Loss expected for Aptevo Therapeutics
January 16, 2018 at 16:36 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|